Suppr超能文献

β-肾上腺素能机制是否参与了肾上腺素能药物的眼压降低作用?

Are beta-adrenergic mechanisms involved in ocular hypotensive actions of adrenergic drugs?

作者信息

Chiou G C, Watanabe K, McLaughlin M A, Liu H K

出版信息

Ophthalmic Res. 1985;17(1):49-53. doi: 10.1159/000265349.

Abstract

Specific beta 1- and beta 2-adrenergic agonists and antagonists were studied for their effects on aqueous humor dynamics in a cat model. Tazolol (beta 1-agonist) reduced formation of aqueous humor more than outflow, while metoprolol (beta 1-antagonist) reduced outflow more than formation. Both salbutamol (beta 2-agonist) and butoxamine (beta 2-antagonist) inhibited aqueous humor formation and aqueous humor outflow to an equal extent. It is concluded that the adrenergic mechanism is functioning only slightly, if at all, in affecting the intraocular pressure. On the other hand, receptor binding experiments on iris-ciliary body showed clearly that there are 40-fold and 281-fold differences in binding affinity of D- and L-isomers of timolol and propranolol, respectively. These results indicate that the adrenergic receptor mechanism does exist in the eye tissues but that it does not control intraocular pressure significantly.

摘要

在猫模型中研究了特定的β1和β2肾上腺素能激动剂及拮抗剂对房水动力学的影响。他唑洛尔(β1激动剂)减少房水生成的作用大于减少房水流出的作用,而美托洛尔(β1拮抗剂)减少房水流出的作用大于减少房水生成的作用。沙丁胺醇(β2激动剂)和布托沙明(β2拮抗剂)对房水生成和房水流出的抑制程度相同。得出的结论是,肾上腺素能机制在影响眼压方面即便起作用,也是微乎其微的。另一方面,虹膜睫状体上的受体结合实验清楚地表明,噻吗洛尔和普萘洛尔的D-和L-异构体的结合亲和力分别存在40倍和281倍的差异。这些结果表明,肾上腺素能受体机制确实存在于眼组织中,但它对眼压的控制作用并不显著。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验